iTeos Therapeutics, Inc. (DELISTED) (ITOS:DL)
10.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 05, 16:00
iTeos Therapeutics EPS Diluted (Quarterly) : -1.807 for June 30, 2025
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | -1.807 |
| March 31, 2025 | -0.8005 |
| December 31, 2024 | -1.195 |
| September 30, 2024 | -1.052 |
| June 30, 2024 | -0.1795 |
| March 31, 2024 | -1.066 |
| December 31, 2023 | -0.8525 |
| September 30, 2023 | -0.901 |
| June 30, 2023 | -0.9589 |
| March 31, 2023 | -0.4354 |
| December 31, 2022 | 0.54 |
| September 30, 2022 | 0.0263 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.1495 |
| March 31, 2022 | 1.825 |
| December 31, 2021 | 4.889 |
| September 30, 2021 | 1.858 |
| June 30, 2021 | -0.7534 |
| March 31, 2021 | -0.3856 |
| December 31, 2020 | -0.4253 |
| September 30, 2020 | -0.3324 |
| June 30, 2020 | -0.294 |
| March 31, 2020 | -0.187 |
| March 31, 2019 | -0.1486 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ZimVie, Inc. (DELISTED) | -0.1408 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Black Titan Corp. | -430.00 |
| Solid Biosciences, Inc. | -0.3814 |
| Replimune Group, Inc. | -0.7202 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -78.73M |
| Total Expenses (Quarterly) | 78.73M |
| Enterprise Value | -61.62M |
| Earnings Yield | -46.21% |
| Normalized Earnings Yield | -47.83 |